Effect of Long-Term Treatment with Vagus Nerve Stimulation on Mood and Quality of Life in Korean Patients with Drug-Resistant Epilepsy
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background and Purpose This study aimed to determine the long-term effects of vagus nerve stimulation (VNS) treatment on suicidality, mood-related symptoms, and quality of life (QOL) in patients with drug-resistant epilepsy (DRE). We also investigated the relationships among these main effects, clinical characteristics, and VNS parameters. Methods Among 35 epilepsy patients who underwent VNS implantation consecutively in our epilepsy center, 25 patients were recruited to this study for assessing the effects of VNS on suicidality, mood-related symptoms, and QOL. The differences in these variables between before and after VNS treatment were analyzed statistically using paired t-tests. Multiple linear regression analyses were also performed to determine how the patients’ demographic and clinical characteristics influenced the variables that showed statistically significant changes after long-term VNS treatment. Results After VNS, our patients showed significant improvements not only in the mean seizure frequency but also in suicidality, depression, and QOL. The reduction in depression was associated with the improvement in QOL and more-severe depression at baseline. The reduction in suicidality was associated with higher suicidality at baseline, smaller changes in depression, and less-severe depression at baseline. Improved QOL was associated with lower suicidality at baseline. Conclusions This study found that VNS decreased the mean seizure frequency in patients with DRE, and also improved their depression, suicidality, and QOL. These results provide further evidence for therapeutic effect of VNS on psychological comorbidities of patients with DRE.
Abstract
Background and Purpose This study aimed to determine the long-term effects of vagus nerve stimulation (VNS) treatment on suicidality, mood-related symptoms, and quality of life (QOL) in patients with drug-resistant epilepsy (DRE). We also investigated the relationships among these main effects, clinical characteristics, and VNS parameters. Methods Among 35 epilepsy patients who underwent VNS implantation consecutively in our epilepsy center, 25 patients were recruited to this study for assessing the effects of VNS on suicidality, mood-related symptoms, and QOL. The differences in these variables between before and after VNS treatment were analyzed statistically using paired t-tests. Multiple linear regression analyses were also performed to determine how the patients’ demographic and clinical characteristics influenced the variables that showed statistically significant changes after long-term VNS treatment. Results After VNS, our patients showed significant improvements not only in the mean seizure frequency but also in suicidality, depression, and QOL. The reduction in depression was associated with the improvement in QOL and more-severe depression at baseline. The reduction in suicidality was associated with higher suicidality at baseline, smaller changes in depression, and less-severe depression at baseline. Improved QOL was associated with lower suicidality at baseline. Conclusions This study found that VNS decreased the mean seizure frequency in patients with DRE, and also improved their depression, suicidality, and QOL. These results provide further evidence for therapeutic effect of VNS on psychological comorbidities of patients with DRE.
참고문헌 (54)
- Hitiris N, "Predictors of pharmacoresistant epilepsy", Epilepsy Res, 75, pp.192~196 (2007)
- Salpekar JA, "Key issues in addressing the comorbidity of depression and pediatric epilepsy", Epilepsy Behav, 46, pp.12~18 (2015)
- Witt JA, "Cognition in epilepsy : current clinical issues of interest", Curr Opin Neurol, 30, pp.174~179 (2017)
- Thompson AW, "Sociodemographic and clinical factors associated with depression in epilepsy", Epilepsy Behav, 14, pp.655~660 (2009)
- Pack AM, "Epilepsy and suicidality : what’s the relationship?", Epilepsy Curr, 16, pp.236~238 (2016)
- Tian N, "Suicide among people with epilepsy : a population-based analysis of data from the U. S. National Violent Death Reporting System, 17 states, 2003-2011", Epilepsy Behav, 61, pp.210~217 (2016)
- Park SJ, "Identifying clinical correlates for suicide among epilepsy patients in South Korea : a case-control study", Epilepsia, 56, pp.1966~1972 (2015)
- Seo JH, "Correlation between headaches and affective symptoms in patients with epilepsy", Epilepsy Behav, 60, pp.204~208 (2016)
- Englot DJ, "Rates and predictors of seizure freedom with vagus nerve stimulation for intractable epilepsy", Neurosurgery, 79, pp.345~353 (2016)
- Harden CL, "A pilot study of mood in epilepsy patients treated with vagus nerve stimulation", Epilepsy Behav, 1, pp.93~99 (2000)
- Elger G, "Vagus nerve stimulation is associated with mood improvements in epilepsy patients", Epilepsy Res, 42, pp.203~210 (2000)
- Klinkenberg S, "Vagus nerve stimulation has a positive effect on mood in patients with refractory epilepsy", Clin Neurol Neurosurg, 114, pp.336~340 (2012)
- Hoppe C, "Self-reported mood changes following 6 months of vagus nerve stimulation in epilepsy patients", Epilepsy Behav, 2, pp.335~342 (2001)
- Ryvlin P, "The long-term effect of vagus nerve stimulation on quality of life in patients with pharmacoresistant focal epilepsy : the PuLsE(Open Prospective Randomized Long-term Effectiveness)trial", Epilepsia, 55, pp.893~900 (2014)
- Sperling MR, "A reappraisal of mortality after epilepsy surgery", Neurology, 86, pp.1938~1944 (2016)
- Choi H, "Epilepsy surgery for pharmacoresistant temporal lobe epilepsy : a decision analysis", JAMA, 300, pp.2497~2505 (2008)
- Wachi M, "Neuropsychological changes after surgical treatment for temporal lobe epilepsy", Epilepsia, 42(Suppl 6), pp.4~8 (2001)
- Westerveld M, "Temporal lobectomy in children : cognitive outcome", J Neurosurg, 92, pp.24~30 (2000)
- Cramer JA, "Exploration of changes in health-related quality of life after 3 months of vagus nerve stimulation", Epilepsy Behav, 2, pp.460~465 (2001)
- McLachlan RS, "Quality of life after vagus nerve stimulation for intractable epilepsy : is seizure control the only contributing factor?", Eur Neurol, 50, pp.16~19 (2003)
- Englot DJ, "Quality-of-life metrics with vagus nerve stimulation for epilepsy from provider survey data", Epilepsy Behav, 66, pp.4~9 (2017)
- Wheless JW, "Vagus nerve stimulation(VNS)therapy update", Epilepsy Behav, 88, pp.2~10 (2018)
- Beck AT, "Manual for the Beck Depression Inventory-II" (1996), Psychological Corporation
- 성형모, "한국어판 백 우울 설문지 2판의 신뢰도 및 타당도 연구", 생물치료정신의학, 14(2), pp.201~212 (2008), 대한생물치료정신의학회
- Beck AT, "An inventory for measuring clinical anxiety : psychometric properties", J Consult Clin Psychol, 56, pp.893~897 (1988)
- Yook SP, "A clinical study on the Korean version of Beck Anxiety Inventory : comparative study of patient and non-patient", Korean J Clin Psychol, 16, pp.185~197 (1997)
- 서종근, "Suicidality and Its Risk Factors in Korean People with Epilepsy: A MEPSY Study", Journal of Clinical Neurology, 11(1), pp.32~41 (2015), 대한신경과학회[DOI]
- Sheehan DV, "Mini-International Neuropsychiatric Interview (M.I.N.I.):the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10", J Clin Psychiatry, 59(Suppl 20), pp.22~33 (1998)
- Yoo HJ, "The reliability and validity of Korean QOLIE-31 in patients with epilepsy", J Korean Epilepsy Soc, 6, pp.45~52 (2002)
- Aaronson ST, "Vagus nerve stimulation therapy randomized to different amounts of electrical charge for treatment-resistant depression : acute and chronic effects", Brain Stimul, 6, pp.631~640 (2013)
- Aaronson ST, "A 5-year observational study of patients with treatment-resistant depression treated with vagus nerve stimulation or treatment as usual : comparison of response, remission, and suicidality", Am J Psychiatry, 174, pp.640~648 (2017)
- Berry SM, "A patient-level meta-analysis of studies evaluating vagus nerve stimulation therapy for treatment-resistant depression", Med Devices(Auckl), 6, pp.17~35 (2013)
- Feldman RL, "Medicare patient experience with vagus nerve stimulation for treatment-resistant depression", J Med Econ, 16, pp.62~74 (2013)
- Müller HHO, "Efficacy and long-term tuning parameters of vagus nerve stimulation in longterm treated depressive patients", J Clin Neurosci, 44, pp.340~341 (2017)
- Müller HH, "The effects of stimulation parameters on clinical outcomes in patients with vagus nerve stimulation implants with major depression", J ECT, 29, pp.e40~ (2013)
- George MS, "Vagus nerve stimulation. A potential therapy for resistant depression?", Psychiatr Clin North Am, 23, pp.757~783 (2000)
- Foltz EJ, "Psychiatric controversies in epilepsy", pp.283~295 (2008), Academic Press
- Reisinger EL, "Individual, seizure-related, and psychosocial predictors of depressive symptoms among people with epilepsy over six months", Epilepsy Behav, 15, pp.196~201 (2009)
- Kuehner C, "Subjective quality of life aspects predict depressive symptoms over time : results from a three-wave longitudinal study", Acta Psychiatr Scand, 120, pp.496~499 (2009)
- Ciuffini R, "Epilepsy and suicide : a narrative review", J Psychopathol, 25, pp.155~161 (2019)
- Kanner AM, "Suicidality and epilepsy : a complex relationship that remains misunderstood and underestimated", Epilepsy Curr, 9, pp.63~66 (2009)
- Hesdorffer DC, "Depression and suicide attempt as risk factors for incident unprovoked seizures", Ann Neurol, 59, pp.35~41 (2006)
- Fazel S, "Premature mortality in epilepsy and the role of psychiatric comorbidity : a total population study", Lancet, 382, pp.1646~1654 (2013)
- Christensen J, "Epilepsy and risk of suicide : a population-based case-control study", Lancet Neurol, 6, pp.693~698 (2007)
- Hesdorffer DC, "Occurrence and recurrence of attempted suicide among people with epilepsy", JAMA Psychiatry, 73, pp.80~86 (2016)
- Balazs J, "Suicidal risk, psychopathology, and quality of life in a clinical population of adolescents", Front Psychiatry, 9, pp.17~ (2018)
- Lee SJ, "Predictors of quality of life and their interrelations in Korean people with epilepsy : a MEPSY study", Seizure, 23, pp.762~768 (2014)
- Birbeck GL, "Seizure reduction and quality of life improvements in people with epilepsy", Epilepsia, 43, pp.535~538 (2002)
- Luoni C, "Determinants of health-related quality of life in pharmacoresistant epilepsy : results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments", Epilepsia, 5, pp.2181~2191 (2011)
- Jehi L, "Quality of life in 1931 adult patients with epilepsy : seizures do not tell the whole story", Epilepsy Behav, 22, pp.723~727 (2011)
- Park SP, "Differential effects of seizure control and affective symptoms on quality of life in people with epilepsy", Epilepsy Behav, 18, pp.455~459 (2010)
- Taylor RS, "Predictors of health-related quality of life and costs in adults with epilepsy : a systematic review", Epilepsia, 52, pp.2168~2180 (2011)
- Amar AP, "An institutional experience with cervical vagus nerve trunk stimulation for medically refractory epilepsy : rationale, technique, and outcome", Neurosurgery, 43, pp.1265~1276 (1998)
- Handforth A, "Vagus nerve stimulation therapy for partialonset seizures : a randomized active-control trial", Neurology, 51, pp.48~55 (1998)